| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |